1,730
Views
31
CrossRef citations to date
0
Altmetric
Research Article

Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy

, , , &
Pages 1369-1373 | Received 24 Mar 2015, Accepted 05 Apr 2015, Published online: 27 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Chiara Ferraris, Roberta Cavalli, Pier Paolo Panciani & Luigi Battaglia. (2020) Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours. International Journal of Nanomedicine 15, pages 2999-3022.
Read now
Gang Yang, Feihua Wu, Minyan Chen, Jian Jin, Rong Wang & Yongfang Yuan. (2019) Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides. International Journal of Nanomedicine 14, pages 2267-2280.
Read now
Jicai Zhang, Xiang Xiao, Jianming Zhu, Ziyun Gao, Xianliang Lai, Xingen Zhu & Guohua Mao. (2018) Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy. International Journal of Nanomedicine 13, pages 3039-3051.
Read now
Jie Qu, Liangqiao Zhang, Zhihua Chen, Guohua Mao, Ziyun Gao, Xianliang Lai, Xingen Zhu & Jianming Zhu. (2016) Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?. Drug Delivery 23:9, pages 3408-3416.
Read now

Articles from other publishers (27)

Karthikeyan Elumalai, Sivaneswari Srinivasan & Anandakumar Shanmugam. (2024) Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment. Biomedical Technology 5, pages 109-122.
Crossref
Sumel Ashique, Ashish Garg, Neeraj Mishra, Neha Raina, Long Chiau Ming, Hardeep Singh Tulli, Tapan Behl, Radha Rani & Madhu Gupta. (2023) Nano-mediated strategy for targeting and treatment of non-small cell lung cancer (NSCLC). Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Jivesh Garg, Khushboo Pathania, Sangeeta Pilkhwal Sah & Sandip V. Pawar. (2022) Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours. Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Ana Raquel Neves, Tânia Albuquerque, Rúben Faria, Ana M. Gonçalves, Cecília Santos, Eric Vivès, Prisca Boisguérin, Luís A. Passarinha, Ângela Sousa & Diana Costa. (2022) Development of WRAP5 Peptide Complexes for Targeted Drug/Gene Co-Delivery toward Glioblastoma Therapy. Pharmaceutics 14:10, pages 2213.
Crossref
Reena Jatyan, Prabhjeet Singh, Deepak Kumar Sahel, Y.G. Karthik, Anupama Mittal & Deepak Chitkara. (2022) Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme. Journal of Controlled Release 350, pages 494-513.
Crossref
Asmaa H. Abdelhameed, Wael A. Abdelhafez, khI. Saleh & Mohamed S. Mohamed. (2022) Formulation, optimization, and in-vivo evaluation of nanostructured lipid carriers loaded with Fexofenadine HCL for oral delivery. Journal of Drug Delivery Science and Technology 74, pages 103607.
Crossref
Tobeka Naki & Blessing A. Aderibigbe. (2022) Efficacy of Polymer-Based Nanomedicine for the Treatment of Brain Cancer. Pharmaceutics 14:5, pages 1048.
Crossref
Sukanya Bhunia & Arabinda Chaudhuri. 2022. Brain Tumors. Brain Tumors.
Bwalya Angel Witika, Madan Sai Poka, Patrick Hulisani Demana, Scott Kaba Matafwali, Siyabonga Melamane, Sandile Maswazi Malungelo Khamanga & Pedzisai Anotida Makoni. (2022) Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date. Pharmaceutics 14:4, pages 836.
Crossref
Gustavo Henrique Rodrigues da Silva, Ludmilla David de Moura, Fabíola Vieira de Carvalho, Gabriela Geronimo, Talita Cesarim Mendonça, Fernando Freitas de Lima & Eneida de Paula. (2021) Antineoplastics Encapsulated in Nanostructured Lipid Carriers. Molecules 26:22, pages 6929.
Crossref
Hamdi Nsairat, Dima Khater, Fadwa Odeh, Fedaa Al-Adaileh, Suma Al-Taher, Areej M. Jaber, Walhan Alshaer, Abeer Al Bawab & Mohammad S. Mubarak. (2021) Lipid nanostructures for targeting brain cancer. Heliyon 7:9, pages e07994.
Crossref
Md. Rizwanullah, Mohammad Zaki Ahmad, Anuj Garg & Javed Ahmad. (2021) Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application. Biochimica et Biophysica Acta (BBA) - General Subjects 1865:9, pages 129936.
Crossref
Kimmy Tran, Ryan Brice & Li Yao. (2021) Bioscaffold-based study of glioblastoma cell behavior and drug delivery for tumor therapy. Neurochemistry International 147, pages 105049.
Crossref
Nupur Shrivastava, Ankit Parikh, Aiswarya Chaudhuri, Javed Ali, Sanjula Baboota & Sanjay Garg. 2021. Nanocarriers for the Delivery of Combination Drugs. Nanocarriers for the Delivery of Combination Drugs 259 305 .
Vinitha Rani, Jayachandran Venkatesan & Ashwini Prabhu. 2021. Nanotechnology in Medicine. Nanotechnology in Medicine 123 139 .
Marc Suñé-Pou, María J. Limeres, Cristina Moreno-Castro, Cristina Hernández-Munain, Josep M. Suñé-Negre, María L. Cuestas & Carlos Suñé. (2020) Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease. Frontiers in Genetics 11.
Crossref
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, Sunil Kumar Dubey, Anu Puri, Ravish J. Patel, Ajazuddin, V. Ravichandiran, Upadhyayula Suryanarayana Murty & Amit Alexander. (2020) Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting. Journal of Controlled Release 321, pages 372-415.
Crossref
Michele d'Angelo, Vanessa Castelli, Elisabetta Benedetti, Andrea Antonosante, Mariano Catanesi, Reyes Dominguez-Benot, Giuseppina Pitari, Rodolfo Ippoliti & Annamaria Cimini. (2019) Theranostic Nanomedicine for Malignant Gliomas. Frontiers in Bioengineering and Biotechnology 7.
Crossref
Raul Ortiz, Laura Cabeza, Gloria Perazzoli, Julia Jimenez-Lopez, Beatriz García-Pinel, Consolación Melguizo & Jose Prados. (2019) Nanoformulations for glioblastoma multiforme: a new hope for treatment. Future Medicinal Chemistry 11:18, pages 2461-2482.
Crossref
Sanjib Bahadur, Arvind Kumar Sahu, Pragya Baghel & Suman Saha. (2019) Current promising treatment strategy for glioblastoma multiform: A review. Oncology Reviews 13:2.
Crossref
Purnima Gupta, Evelyn Garcia, Amrita Sarkar, Sumit Kapoor, Khadija Rafiq, Hitendra S. Chand & Rahul Dev Jayant. (2019) Nanoparticle Based Treatment for Cardiovascular Diseases. Cardiovascular & Hematological Disorders-Drug Targets 19:1, pages 33-44.
Crossref
Josef Jampílek & Katarína Kráľová. 2019. Nanoarchitectonics in Biomedicine. Nanoarchitectonics in Biomedicine 219 294 .
Jacob S. Young, Giovanna Bernal, Sean P. Polster, Luis Nunez, Gustavo F. Larsen, Nassir Mansour, Michael Podell & Bakhtiar Yamini. (2018) Convection-Enhanced Delivery of Polymeric Nanoparticles Encapsulating Chemotherapy in Canines with Spontaneous Supratentorial Tumors. World Neurosurgery 117, pages e698-e704.
Crossref
Riyaz Ali M. Osmani, Parthasarathi K. Kulkarni, Vishakante Gowda, Umme Hani, Vishal K. Gupta, Madesh Prerana & Chandani Saha. 2018. Applications of Nanocomposite Materials in Drug Delivery. Applications of Nanocomposite Materials in Drug Delivery 97 147 .
Maria J. Ramalho, Manuel A.N. Coelho & Maria C. Pereira. 2018. Design and Development of New Nanocarriers. Design and Development of New Nanocarriers 687 722 .
Christos Tapeinos, Matteo Battaglini & Gianni Ciofani. (2017) Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. Journal of Controlled Release 264, pages 306-332.
Crossref
Slavomira Doktorovová, Andjelka B. Kovačević, Maria L. Garcia & Eliana B. Souto. (2016) Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation. European Journal of Pharmaceutics and Biopharmaceutics 108, pages 235-252.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.